Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| May 17, 2026 | Regence BCBS | Femoroacetabular Impingement SurgeryPayerPolicy · REGENCE-SUR160 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Extravascular (Substernal) Implantable Cardioverter-DefibrillatorPayerPolicy · REGENCE-SUR17 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Extracranial Carotid Angioplasty and StentingPayerPolicy · REGENCE-SUR93 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Extracorporeal Shock Wave Therapy (ESWT)PayerPolicy · REGENCE-MED90 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | External Trigeminal Nerve Stimulation for the Treatment of Attention Deficit Hyperactivity DisorderPayerPolicy · REGENCE-DME83.14 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Expanded Molecular Testing of Cancers to Select Targeted TherapiesPayerPolicy · REGENCE-GT83 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Evaluating the Utility of Genetic PanelsPayerPolicy · REGENCE-GT64 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Enteral and Oral Nutrition in the Home SettingPayerPolicy · REGENCE-AH05 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Endometrial AblationPayerPolicy · REGENCE-SUR01 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Electromagnetic TherapyPayerPolicy · REGENCE-DME83.13 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Electromagnetic Navigation BronchoscopyPayerPolicy · REGENCE-SUR179 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Electrical Stimulation for the Treatment of WoundsPayerPolicy · REGENCE-DME83.09 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Electrical Stimulation for the Treatment of ArthritisPayerPolicy · REGENCE-DME83.10 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Electrical Bone Growth Stimulators (Osteogenic Stimulation)PayerPolicy · REGENCE-DME83.11 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Dynamic Stabilization of the SpinePayerPolicy · REGENCE-SUR143 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Durable Medical Equipment,Prosthetic and Orthotic Replacements,Duplicates,Repairs,and Upgrades to Existing EquipmentPayerPolicy · REGENCE-DME75 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Dual Chamber Leadless Cardiac PacemakersPayerPolicy · REGENCE-SUR217 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Dry NeedlingPayerPolicy · REGENCE-MED39 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Drug Testing for Substance Use and Pain ManagementPayerPolicy · REGENCE-LAB68 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Donor Lymphocyte Infusion for Malignancies Treated with an Allogeneic Hematopoietic Cell TransplantPayerPolicy · REGENCE-TRA45.03 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Digital Therapeutic Products for Substance Use DisordersPayerPolicy · REGENCE-MED175.02 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Digital Therapeutic Products for Post-traumatic Stress Disorder and Panic DisorderPayerPolicy · REGENCE-MED175.05 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Digital Therapeutic Products for Gait TrainingPayerPolicy · REGENCE-MED175.06 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Digital Therapeutic Products for Chronic Low Back PainPayerPolicy · REGENCE-MED175.03 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Digital Therapeutic Products for Attention Deficit Hyperactivity DisorderPayerPolicy · REGENCE-MED175.01 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Digital Therapeutic Products for AmblyopiaPayerPolicy · REGENCE-MED175.04 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Digital Therapeutic ProductsPayerPolicy · REGENCE-MED175 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Diagnostic Genetic Testing for α-ThalassemiaPayerPolicy · REGENCE-GT52 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Diagnostic Genetic Testing for FMR1 and AFF2 Variants (including Fragile X and Fragile XE Syndromes)PayerPolicy · REGENCE-GT43 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Devices for Treatment of Benign Prostatic Hyperplasia,Urethral Stricture,and Urethral StenosisPayerPolicy · REGENCE-SUR230 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Dermabrasion or MicrodermabrasionPayerPolicy · REGENCE-SUR12.04 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Dental and Orthodontic Treatment for Craniofacial AnomaliesPayerPolicy · REGENCE-AH33 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Definitive Lower Limb ProsthesesPayerPolicy · REGENCE-DME18 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Deep Brain StimulationPayerPolicy · REGENCE-SUR84 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Decompression of Intervertebral Discs Using Laser Energy (Laser Discectomy) or Radiofrequency Energy (Nucleoplasty)PayerPolicy · REGENCE-SUR131 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Cytochrome p450 and VKORC1 Genotyping for Treatment Selection and DosingPayerPolicy · REGENCE-GT10 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Cryosurgical Ablation of Miscellaneous Solid Tumors Outside of the LiverPayerPolicy · REGENCE-SUR132 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Cranial Electrostimulation Therapy (CES)PayerPolicy · REGENCE-DME83.06 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | COVID-19 TestingPayerPolicy · REGENCE-LAB74 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Coverage of Treatments Provided in a Clinical TrialPayerPolicy · REGENCE-MED150 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Cosmetic and Reconstructive ProceduresPayerPolicy · REGENCE-SUR12 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Cooling Devices Used in the Home SettingPayerPolicy · REGENCE-DME07 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Confocal Laser EndomicroscopyPayerPolicy · REGENCE-MED151 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Cone Beam Computed Tomography of the BreastPayerPolicy · REGENCE-RAD59 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Computed Tomography to Detect Coronary Artery CalcificationsPayerPolicy · REGENCE-RAD06 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Cochlear ImplantPayerPolicy · REGENCE-SUR08 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | ClonoSEQ Testing for the Assessment of Measurable Residual Disease (MRD)PayerPolicy · REGENCE-GT88 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Circulating Tumor-Tissue Modified Viral DNA Testing for Cancer ManagementPayerPolicy · REGENCE-LAB82 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Circulating Tumor DNA and Circulating Tumor Cells for Management (Liquid Biopsy) of Solid Tumor CancersPayerPolicy · REGENCE-LAB46 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Chromosomal Microarray Analysis (CMA) or Copy Number Analysis for the Genetic Evaluation of Patients with Developmental Delay, Intellectual Disability, Autism Spectrum Disorder, or Congenital AnomaliesPayerPolicy · REGENCE-GT58 | Criteria changed |
|---|